Evidence map›Paper›PMID 25206324›Full record

ArticleFrontiers in neuroanatomy2014

Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons.

Domingo Afonso-Oramas, Ignacio Cruz-Muros, Javier Castro-Hernández, Josmar Salas-Hernández, Pedro Barroso-Chinea, Sonia García-Hernández, José L Lanciego, Tomás González-Hernández

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroanatomy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Domingo Afonso-OramasDepartment of Anatomy, Faculty of Medicine, University of La Laguna La Laguna, Tenerife, Spain ; Biomedical Technologies Institute (ITB, CIBICAN) La Laguna, Tenerife, Spain ; Spanish Network of Neurodegenerative Diseases (CIBERNED) Madrid, Spain.
Ignacio Cruz-MurosDepartment of Anatomy, Faculty of Medicine, University of La Laguna La Laguna, Tenerife, Spain ; Biomedical Technologies Institute (ITB, CIBICAN) La Laguna, Tenerife, Spain ; Spanish Network of Neurodegenerative Diseases (CIBERNED) Madrid, Spain.
Javier Castro-HernándezDepartment of Anatomy, Faculty of Medicine, University of La Laguna La Laguna, Tenerife, Spain ; Biomedical Technologies Institute (ITB, CIBICAN) La Laguna, Tenerife, Spain.
Josmar Salas-HernándezDepartment of Anatomy, Faculty of Medicine, University of La Laguna La Laguna, Tenerife, Spain ; Spanish Network of Neurodegenerative Diseases (CIBERNED) Madrid, Spain.
Pedro Barroso-ChineaDepartment of Anatomy, Faculty of Medicine, University of La Laguna La Laguna, Tenerife, Spain ; Biomedical Technologies Institute (ITB, CIBICAN) La Laguna, Tenerife, Spain.
Sonia García-HernándezDepartment of Pathology, University Hospital of Canary Islands Tenerife, Spain.
José L LanciegoSpanish Network of Neurodegenerative Diseases (CIBERNED) Madrid, Spain ; Center for Applied Medical Research (CIMA), University of Navarra Pamplona, Spain.
Tomás González-HernándezDepartment of Anatomy, Faculty of Medicine, University of La Laguna La Laguna, Tenerife, Spain ; Biomedical Technologies Institute (ITB, CIBICAN) La Laguna, Tenerife, Spain ; Spanish Network of Neurodegenerative Diseases (CIBERNED) Madrid, Spain.
Universidad de La Laguna · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESHospital Universitario de Canarias · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays it is assumed that besides its roles in neuronal processing, dopamine (DA) is also involved in the regulation of cerebral blood flow. However, studies on the hemodynamic actions of DA have been mainly focused on the cerebral cortex, but the possibility that vessels in deeper brain structures receive dopaminergic axons and the origin of these axons have not been investigated. Bearing in mind the evidence of changes in the blood flow of basal ganglia in Parkinson's disease (PD), and the pivotal role of the dopaminergic mesostriatal pathway in the pathophysiology of this disease, here we studied whether striatal vessels receive inputs from midbrain dopaminergic neurons. The injection of an anterograde neuronal tracer in combination with immunohistochemistry for dopaminergic, vascular and astroglial markers, and dopaminergic lesions, revealed that midbrain dopaminergic axons are in close apposition to striatal vessels and perivascular astrocytes. These axons form dense perivascular plexuses restricted to striatal regions in rats and monkeys. Interestingly, they are intensely immunoreactive for tyrosine hydroxylase (TH) phosphorylated at Ser19 and Ser40 residues. The presence of phosphorylated TH in vessel terminals indicates they are probably the main source of basal TH activity in the striatum, and that after activation of midbrain dopaminergic neurons, DA release onto vessels precedes that onto neurons. Furthermore, the relative weight of this "vascular component" within the mesostriatal pathway suggests that it plays a relevant role in the pathophysiology of PD.

Indexed as

cerebral blood flowdopaminemidbrainParkinson’s diseaseSer 19Ser 40striatum

Identifiers

PMID25206324
PMCPMC4144090
OpenAlexW2171078256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.